• No results found

TARGETED THERAPY FOR TRIPLE- NEGATIVE BREAST CANCER

N/A
N/A
Protected

Academic year: 2021

Share "TARGETED THERAPY FOR TRIPLE- NEGATIVE BREAST CANCER"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/68194 holds various files of this Leiden University dissertation.

Author: McLaughlin, R.P.

Title: Targeted therapy for triple-negative breast cancer Issue Date: 2018-12-13

(2)

TARGETED THERAPY FOR TRIPLE- NEGATIVE BREAST CANCER

RONAN PATRICK MCLAUGHLIN

Referenties

GERELATEERDE DOCUMENTEN

To support such a selec- tion, we established an in silico web tool in to allow (1) differential expression of genes between 2 and 3D BC cell lines, (2) collect gene expression

Two hypotheses based on previous publications were studied [ 7 , 8 ]: (1) compared with MTC, BCT results in a better QoL and (2) personality, and especially trait anxiety, will have

Therefore, it uses organizational learning theory in two ways: to explain that the effects of individual learning are different from group learning methods and to link the

An indicator of its potential is the broad range of companies from very different sectors that have started to operate car-sharing services: automotive vehicle manufacturers,

The analysis will provide the variables involved in the process of scaling up and out (Pitt, 2016) these farms to different contexts, which will be used later on in the

vragen zonder ​ ​het​ ​gebruik​ ​van​ ​een​ ​woordenboek​ ​of​ ​andere​ ​hulpmiddelen.!. Maak ​ ​hierbij​ ​geen gebruik​ ​van​

Migration assays were performed on several cell models modulated for ZEB2 and/or miR-30a expression, namely: MDA231, MDA157, BT549, Hs578T and HCC1395 stably silenced for ZEB2

Shown are hazard ratios and estimates of disease‑free survival, freedom from distant recurrence, and overall survival among patients with HER2‑negative breast cancer who